Many clinical trials of new cancer drugs may be inappropriately excluding some people with Duffy-null phenotype, a trait found predominantly in people of African or Middle Eastern descent, researchers report in a new study.
Read more https://www.sciencedaily.com/releases/2024/09/240911112138.htm